Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS)
Clinical trial NCT00950248 · COMPLETED
Trial details
- NCT number
- NCT00950248
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2018-04-30
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.